Ron Golan

NewYork–Presbyterian Hospital

Papers

1

Total Citations

3

H-Index

1

About

Ron Golan is a urologic surgeon and researcher whose work focuses on optimizing surgical outcomes in kidney cancer treatment, particularly through partial nephrectomy. His key research areas include surgical oncology, renal mass management, and the technical determinants of oncologic success. Golan’s major contribution lies in challenging prevailing assumptions about surgical approach and margin status. In his most cited work, “Surgical Approach Does Not Impact Margin Status After Partial Nephrectomy for Large Renal Masses,” he demonstrated that for tumors larger than 4 cm, the choice between open, laparoscopic, or robotic surgery does not significantly affect positive surgical margin rates—a finding that empowers surgeons to prioritize minimally invasive techniques without compromising cancer control. Though his citation count is modest, this study addresses a critical gap in the literature, offering evidence-based reassurance for complex nephron-sparing surgery. Golan’s work exemplifies how rigorous, clinically focused research can directly influence operative decision-making and patient outcomes. His contributions are particularly valuable for trainees and practitioners navigating the balance between technical innovation and oncologic safety in urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Surgical Approach Does Not Impact Margin Status After Partial Nephrectomy for Large Renal Masses
3 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: NewYork–Presbyterian Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago